Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice
- 10 September 1999
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 67 (2), 135-142
- https://doi.org/10.1016/s0378-8741(98)00242-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Acute and subchronic toxicity of thymoquinone in miceDrug Development Research, 1998
- Antitumour activity and schedule dependency of 8-chloroadenosine-3′,5′-monophosphate (8-ClcAMP) against human tumour xenograftsEuropean Journal Of Cancer, 1998
- Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activityCanadian Journal of Physiology and Pharmacology, 1997
- Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in ratsKidney International, 1996
- Strategies to prevent nephrotoxicity of anticancer drugsCurrent Opinion in Oncology, 1995
- Fixed Oil ofNigella sativaand Derived Thymoquinone Inhibit Eicosanoid Generation in Leukocytes and Membrane Lipid PeroxidationPlanta Medica, 1995
- Ifosfamide Metabolite Chloroacetaldehyde Causes Fanconi Syndrome in the Perfused Rat KidneyToxicology and Applied Pharmacology, 1994
- Antitumour principles from Nigella sativa seedsCancer Letters, 1992
- Drug Interaction Effects on Antitumour Drugs (VIII): Prevention of Ifosfamide-Induced Urotoxicity by Disulfiram and its Effect on Antitumour Activity and Acute Toxicity of Alkylating Agents in MiceBasic & Clinical Pharmacology & Toxicology, 1991
- Determination of blood glucose using 4-amino phenazone as oxygen acceptor.Journal of Clinical Pathology, 1969